| Comparative effectiveness of thermal ablation, surgical resection, and active surveillance for T1a renal cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER … M Xing, N Kokabi, D Zhang, JM Ludwig, HS Kim Radiology 288 (1), 81-90, 2018 | 103 | 2018 |
| Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict … JC Camacho, N Kokabi, M Xing, HJ Prajapati, B El-Rayes, HS Kim Journal of Vascular and Interventional Radiology 25 (2), 256-265, 2014 | 99 | 2014 |
| Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC HJ Prajapati, M Xing, JR Spivey, SI Hanish, BF El-Rayes, JS Kauh, ... American Journal of Roentgenology 203 (6), W706-W714, 2014 | 87 | 2014 |
| RENAL (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor … JC Camacho, N Kokabi, M Xing, VA Master, JG Pattaras, PK Mittal, ... Journal of Vascular and Interventional Radiology 26 (5), 686-693, 2015 | 71 | 2015 |
| Open‐label prospective study of the safety and efficacy of glass‐based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis N Kokabi, JC Camacho, M Xing, BF El‐Rayes, JR Spivey, SJ Knechtle, ... Cancer 121 (13), 2164-2174, 2015 | 65 | 2015 |
| Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to … M Xing, HJ Prajapati, R Dhanasekaran, DH Lawson, N Kokabi, BR Eaton, ... American journal of clinical oncology 40 (1), 27-34, 2017 | 55 | 2017 |
| A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study N Kokabi, JR Galt, M Xing, JC Camacho, BJ Barron, DM Schuster, HS Kim Journal of Vascular and Interventional Radiology 25 (2), 277-287, 2014 | 54 | 2014 |
| Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable … N Kokabi, JC Camacho, M Xing, D Qiu, H Kitajima, PK Mittal, HS Kim Abdominal imaging 39, 969-978, 2014 | 50 | 2014 |
| KRAS status as an independent prognostic factor for survival after yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastases SJ Lahti, M Xing, D Zhang, JJ Lee, MJ Magnetta, HS Kim Journal of vascular and interventional radiology 26 (8), 1102-1111, 2015 | 49 | 2015 |
| Covered stents and coil embolization for treatment of postpancreatectomy arterial hemorrhage KC Ching, E Santos, KM McCluskey, PD Orons, R Bandi, CJ Friend, ... Journal of Vascular and Interventional Radiology 27 (1), 73-79, 2016 | 47 | 2016 |
| Locoregional therapies for metastatic colorectal carcinoma to the liver—An evidence‐based review M Xing, DA Kooby, BF El‐Rayes, N Kokabi, JC Camacho, HS Kim Journal of Surgical Oncology 110 (2), 182-196, 2014 | 46 | 2014 |
| Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes J Uhlig, N Kokabi, M Xing, HS Kim Radiology 288 (3), 889-897, 2018 | 41 | 2018 |
| Effect of bridging local-regional therapy on recurrence of hepatocellular carcinoma and survival after orthotopic liver transplantation HC Oligane, M Xing, HS Kim Radiology 282 (3), 869-879, 2017 | 40 | 2017 |
| 90Y radioembolization lung shunt fraction in primary and metastatic liver cancer as a biomarker for survival M Xing, S Lahti, N Kokabi, DM Schuster, JC Camacho, HS Kim Clinical Nuclear Medicine 41 (1), 21-27, 2016 | 37 | 2016 |
| Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead … N Kokabi, JM Ludwig, JC Camacho, M Xing, PK Mittal, HS Kim Journal of Vascular and Interventional Radiology 26 (12), 1777-1786, 2015 | 37 | 2015 |
| The role of diffusion-weighted imaging (DWI) in locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional … JM Ludwig, JC Camacho, N Kokabi, M Xing, HS Kim Diagnostics 5 (4), 546-563, 2015 | 37 | 2015 |
| Diagnostic utility of MRI and MR arthrography for detection of ligamentum teres tears: a retrospective analysis of 187 patients with hip pain A Datir, M Xing, J Kang, P Harkey, A Kakarala, WA Carpenter, MR Terk American Journal of Roentgenology 203 (2), 418-423, 2014 | 37 | 2014 |
| Preservation of quality of life with doxorubicin drug‐eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study M Xing, G Webber, HJ Prajapati, Z Chen, B El‐Rayes, JR Spivey, AA Pillai, ... Journal of Gastroenterology and Hepatology 30 (7), 1167-1174, 2015 | 33 | 2015 |
| Tanzania IR initiative: training the first generation of interventional radiologists FML Gaupp, N Solomon, I Rukundo, AA Naif, EM Mbuguje, A Gonchigar, ... Journal of Vascular and Interventional Radiology 30 (12), 2036-2040, 2019 | 31 | 2019 |
| Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma JM Ludwig, D Zhang, M Xing, HS Kim European radiology 27, 2031-2041, 2017 | 31 | 2017 |
